{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T08:06:52Z","timestamp":1790237212341,"version":"4.1.0"},"reference-count":38,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":467,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Clin Pharmacol"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1111\/bcp.12276","type":"journal-article","created":{"date-parts":[[2013,11,6]],"date-time":"2013-11-06T09:19:49Z","timestamp":1383729589000},"page":"1051-1063","source":"Crossref","is-referenced-by-count":24,"title":["Population pharmacokinetics and Bayesian estimation of tacrolimus exposure in paediatric liver transplant recipients"],"prefix":"10.1111","volume":"77","author":[{"given":"Nastya","family":"Kassir","sequence":"first","affiliation":[{"name":"Clinical Pharmacology Unit; CHU Ste-Justine; Montreal Quebec Canada"},{"name":"Faculty of Pharmacy; Universit\u00e9 de Montr\u00e9al; Montreal Quebec Canada"},{"name":"Pharsight - A Certara Company; Montreal Quebec Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Line","family":"Labb\u00e9","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy; Universit\u00e9 de Montr\u00e9al; Montreal Quebec Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Romain","family":"Delaloye","sequence":"additional","affiliation":[{"name":"Clinical Pharmacology Unit; CHU Ste-Justine; Montreal Quebec Canada"},{"name":"Department of Surgery; CHU Ste-Justine; Montreal Quebec Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad-Samer","family":"Mouksassi","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy; Universit\u00e9 de Montr\u00e9al; Montreal Quebec Canada"},{"name":"Pharsight - A Certara Company; Montreal Quebec Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Laure","family":"Lapeyraque","sequence":"additional","affiliation":[{"name":"Clinical Pharmacology Unit; CHU Ste-Justine; Montreal Quebec Canada"},{"name":"Department of Paediatrics; CHU Ste-Justine; Montreal Quebec Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Alvarez","sequence":"additional","affiliation":[{"name":"Department of Paediatrics; CHU Ste-Justine; Montreal Quebec Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Lallier","sequence":"additional","affiliation":[{"name":"Department of Surgery; CHU Ste-Justine; Montreal Quebec Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Beaunoyer","sequence":"additional","affiliation":[{"name":"Department of Surgery; CHU Ste-Justine; Montreal Quebec Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Th\u00e9or\u00eat","sequence":"additional","affiliation":[{"name":"Clinical Pharmacology Unit; CHU Ste-Justine; Montreal Quebec Canada"},{"name":"Department of Biochemistry; CHU Ste-Justine; Montreal Quebec Canada"},{"name":"Department of Pharmacology; Universit\u00e9 de Montr\u00e9al; Montreal Quebec Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Litalien","sequence":"additional","affiliation":[{"name":"Clinical Pharmacology Unit; CHU Ste-Justine; Montreal Quebec Canada"},{"name":"Department of Paediatrics; CHU Ste-Justine; Montreal Quebec Canada"},{"name":"Department of Pharmacology; Universit\u00e9 de Montr\u00e9al; Montreal Quebec Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,5,22]]},"reference":[{"key":"10.1111\/bcp.12276-BIB0001|bcp12276-cit-0001","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/FTD.0b013e318198d092","article-title":"Opportunities to optimize tacrolimus therapy in solid organ transplantation: report of the European consensus conference","volume":"31","author":"Wallemacq","year":"2009","journal-title":"Ther Drug Monit"},{"key":"10.1111\/bcp.12276-BIB0002|bcp12276-cit-0002","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF03192295","article-title":"Pharmacokinetics of tacrolimus (FK506) in paediatric liver transplant recipients","volume":"23","author":"Wallemacq","year":"1998","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"10.1111\/bcp.12276-BIB0003|bcp12276-cit-0003","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2165\/00003088-200140040-00004","article-title":"Comparative clinical pharmacokinetics of tacrolimus in paediatric and adult patients","volume":"40","author":"Wallemacq","year":"2001","journal-title":"Clin Pharmacokinet"},{"key":"10.1111\/bcp.12276-BIB0004|bcp12276-cit-0004","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s00467-009-1331-6","article-title":"Pharmacokinetics of tacrolimus in stable paediatric renal transplant recipients","volume":"25","author":"Claeys","year":"2010","journal-title":"Pediatr Nephrol"},{"key":"10.1111\/bcp.12276-BIB0005|bcp12276-cit-0005","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1034\/j.1399-3046.2002.02039.x","article-title":"Universal approach to pharmacokinetic monitoring of immunosuppressive agents in children","volume":"6","author":"Filler","year":"2002","journal-title":"Pediatr Transplant"},{"key":"10.1111\/bcp.12276-BIB0006|bcp12276-cit-0006","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s00467-006-0014-9","article-title":"The pharmacokinetics and immunosuppressive response of tacrolimus in paediatric renal transplant recipients","volume":"21","author":"Montini","year":"2006","journal-title":"Pediatr Nephrol."},{"key":"10.1111\/bcp.12276-BIB0007|bcp12276-cit-0007","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/01.ftd.0000211810.19935.44","article-title":"Beyond cyclosporine: a systematic review of limited sampling strategies for other immunosuppressants","volume":"28","author":"Ting","year":"2006","journal-title":"Ther Drug Monit"},{"key":"10.1111\/bcp.12276-BIB0008|bcp12276-cit-0008","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1472-6947-8-6","article-title":"Integration of modeling and simulation into hospital-based decision support systems guiding pediatric pharmacotherapy","volume":"8","author":"Barrett","year":"2008","journal-title":"BMC Med Inform Decis Mak"},{"key":"10.1111\/bcp.12276-BIB0009|bcp12276-cit-0009","doi-asserted-by":"crossref","first-page":"805","DOI":"10.2165\/11318080-000000000-00000","article-title":"Tacrolimus population pharmacokinetic-pharmacogenetic analysis and Bayesian estimation in renal transplant recipients","volume":"48","author":"Benkali","year":"2009","journal-title":"Clin Pharmacokinet"},{"key":"10.1111\/bcp.12276-BIB0010|bcp12276-cit-0010","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1365-2125.2010.03815.x","article-title":"Evaluation of limited sampling methods for estimation of tacrolimus exposure in adult kidney transplant recipients","volume":"71","author":"Barraclough","year":"2011","journal-title":"Br J Clin Pharmacol"},{"key":"10.1111\/bcp.12276-BIB0011|bcp12276-cit-0011","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2165\/11594760-000000000-00000","article-title":"Population pharmacokinetic modelling and design of a Bayesian estimator for therapeutic drug monitoring of tacrolimus in lung transplantation","volume":"51","author":"Monchaud","year":"2012","journal-title":"Clin Pharmacokinet"},{"key":"10.1111\/bcp.12276-BIB0012|bcp12276-cit-0012","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.clpt.2006.06.008","article-title":"Population pharmacokinetic and pharmacogenomic analysis of tacrolimus in pediatric living-donor liver transplant recipients","volume":"80","author":"Fukudo","year":"2006","journal-title":"Clin Pharmacol Ther"},{"key":"10.1111\/bcp.12276-BIB0013|bcp12276-cit-0013","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1097\/00007890-200109270-00013","article-title":"Population pharmacokinetics of tacrolimus in children who receive cut-down or full liver transplants","volume":"72","author":"Staatz","year":"2001","journal-title":"Transplantation"},{"key":"10.1111\/bcp.12276-BIB0014|bcp12276-cit-0014","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1046\/j.1365-2125.2000.00288.x","article-title":"Population pharmacokinetics of tacrolimus in Asian paediatric liver transplant patients","volume":"50","author":"Sam","year":"2000","journal-title":"Br J Clin Pharmacol"},{"key":"10.1111\/bcp.12276-BIB0015|bcp12276-cit-0015","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2165\/00003088-200140010-00005","article-title":"Covariate effects on the apparent clearance of tacrolimus in paediatric liver transplant patients undergoing conversion therapy","volume":"40","author":"Garcia Sanchez","year":"2001","journal-title":"Clin Pharmacokinet"},{"key":"10.1111\/bcp.12276-BIB0016|bcp12276-cit-0016","doi-asserted-by":"crossref","first-page":"404","DOI":"10.2165\/00003088-199529060-00003","article-title":"Clinical pharmacokinetics of tacrolimus","volume":"29","author":"Venkataramanan","year":"1995","journal-title":"Clin Pharmacokinet"},{"key":"10.1111\/bcp.12276-BIB0017|bcp12276-cit-0017","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1097\/FTD.0b013e31823415cc","article-title":"Population pharmacokinetics of tacrolimus in pediatric liver transplantation: early posttransplantation clearance","volume":"33","author":"Wallin","year":"2011","journal-title":"Ther Drug Monit"},{"key":"10.1111\/bcp.12276-BIB0018|bcp12276-cit-0018","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/bcp.12174","article-title":"Population pharmacokinetic and pharmacogenetic analysis of tacrolimus in paediatric liver transplant patients","volume":"77","author":"Abdel Jalil","year":"2014","journal-title":"Br J Clin Pharmacol"},{"key":"10.1111\/bcp.12276-BIB0019|bcp12276-cit-0019","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1007\/s00228-013-1501-0","article-title":"Population pharmacokinetic analysis of tacrolimus in the first year after pediatric liver transplantation","volume":"69","author":"Guy-Viterbo","year":"2013","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1111\/bcp.12276-BIB0020|bcp12276-cit-0020","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s00431-006-0188-y","article-title":"Population clinical pharmacology of children: general principles","volume":"165","author":"Anderson","year":"2006","journal-title":"Eur J Pediatr"},{"key":"10.1111\/bcp.12276-BIB0021|bcp12276-cit-0021","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s00431-006-0189-x","article-title":"Population clinical pharmacology of children: modelling covariate effects","volume":"165","author":"Anderson","year":"2006","journal-title":"Eur J Pediatr"},{"key":"10.1111\/bcp.12276-BIB0022|bcp12276-cit-0022","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/sj.clpt.6100241","article-title":"Diagnosing model diagnostics","volume":"82","author":"Karlsson","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"10.1111\/bcp.12276-BIB0023|bcp12276-cit-0023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cccn.2005.04.002","article-title":"The bootstrap: a technique for data-driven statistics. Using computer-intensive analyses to explore experimental data","volume":"359","author":"Henderson","year":"2005","journal-title":"Clin Chim Acta"},{"key":"10.1111\/bcp.12276-BIB0024|bcp12276-cit-0024","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/FTD.0b013e318220bc64","article-title":"Limited sampling strategies for monitoring tacrolimus in pediatric liver transplant recipients","volume":"33","author":"Delaloye","year":"2011","journal-title":"Ther Drug Monit"},{"key":"10.1111\/bcp.12276-BIB0025|bcp12276-cit-0025","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/BF01060893","article-title":"Some suggestions for measuring predictive performance","volume":"9","author":"Sheiner","year":"1981","journal-title":"J Pharmacokinet Biopharm"},{"key":"10.1111\/bcp.12276-BIB0026|bcp12276-cit-0026","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/00007691-200104000-00003","article-title":"Limited sampling strategies for estimating cyclosporin area under the concentration-time curve: review of current algorithms","volume":"23","author":"David","year":"2001","journal-title":"Ther Drug Monit"},{"key":"10.1111\/bcp.12276-BIB0027|bcp12276-cit-0027","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2165\/00003088-199630050-00001","article-title":"A size standard for pharmacokinetics","volume":"30","author":"Holford","year":"1996","journal-title":"Clin Pharmacokinet"},{"key":"10.1111\/bcp.12276-BIB0028|bcp12276-cit-0028","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1016\/S0041-1345(00)01618-3","article-title":"Correlation between graft size and necessary tacrolimus dose after living-related liver transplantation","volume":"32","author":"Harihara","year":"2000","journal-title":"Transplant Proc"},{"key":"10.1111\/bcp.12276-BIB0029|bcp12276-cit-0029","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1034\/j.1399-0012.2002.1o106.x","article-title":"Correlation between optimal tacrolimus doses and the graft weight in living donor liver transplantation","volume":"16","author":"Sugawara","year":"2002","journal-title":"Clin Transplant"},{"key":"10.1111\/bcp.12276-BIB0030|bcp12276-cit-0030","first-page":"1108","article-title":"Pharmacokinetics and pharmacodynamics of FK 506 in pediatric patients receiving living-related donor liver transplantations","volume":"27","author":"Yasuhara","year":"1995","journal-title":"Transplant Proc"},{"key":"10.1111\/bcp.12276-BIB0031|bcp12276-cit-0031","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1399-3046.2005.00263.x","article-title":"Effect of age, ethnicity, and glucocorticoid use on tacrolimus pharmacokinetics in pediatric renal transplant patients","volume":"9","author":"Kim","year":"2005","journal-title":"Pediatr Transplant"},{"key":"10.1111\/bcp.12276-BIB0032|bcp12276-cit-0032","doi-asserted-by":"crossref","first-page":"623","DOI":"10.2165\/00003088-200443100-00001","article-title":"Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation","volume":"43","author":"Staatz","year":"2004","journal-title":"Clin Pharmacokinet"},{"key":"10.1111\/bcp.12276-BIB0033|bcp12276-cit-0033","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/clpt.2009.210","article-title":"Population pharmacokinetics and pharmacogenetics of tacrolimus in de novo pediatric kidney transplant recipients","volume":"86","author":"Zhao","year":"2009","journal-title":"Clin Pharmacol Ther"},{"key":"10.1111\/bcp.12276-BIB0034|bcp12276-cit-0034","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2165\/11317350-000000000-00000","article-title":"Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: part I","volume":"49","author":"Staatz","year":"2010","journal-title":"Clin Pharmacokinet"},{"key":"10.1111\/bcp.12276-BIB0035|bcp12276-cit-0035","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/ajhp\/54.2.178","article-title":"Stability of tacrolimus in an extemporaneously compounded oral liquid","volume":"54","author":"Jacobson","year":"1997","journal-title":"Am J Health Syst Pharm"},{"key":"10.1111\/bcp.12276-BIB0036|bcp12276-cit-0036","unstructured":"U.S. Department of Health Services, Food and drug Administration Guidance for Industry Population Pharmacokinetics 1999 http:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/UCM072137.pdf"},{"key":"10.1111\/bcp.12276-BIB0037|bcp12276-cit-0037","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1034\/j.1399-3046.2000.00093.x","article-title":"Therapeutic drug monitoring of cyclosporin A: should we use the area under the concentration-time curve and forget trough levels?","volume":"4","author":"Hoyer","year":"2000","journal-title":"Pediatr Transplant"},{"key":"10.1111\/bcp.12276-BIB0038|bcp12276-cit-0038","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/FTD.0b013e31820f40f8","article-title":"Optimal sampling strategy development methodology using maximum a posteriori Bayesian estimation","volume":"33","author":"Meer","year":"2011","journal-title":"Ther Drug Monit"}],"container-title":["British Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbcp.12276","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/bcp.12276\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,11]],"date-time":"2022-03-11T17:36:35Z","timestamp":1647020195000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/bcp.12276"}},"subtitle":["Tacrolimus in paediatric liver transplant recipients"],"short-title":[],"issued":{"date-parts":[[2014,5,22]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"URL":"https:\/\/doi.org\/10.1111\/bcp.12276","relation":{},"ISSN":["0306-5251"],"issn-type":[{"value":"0306-5251","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5,22]]}}}